GBUK Group

Explore the most recent news and cutting-edge innovations in medical devices from GBUK Group staying informed about their latest developments and advancements in the field of medical devices.

  • admin
  • No Comments

Christmas & New Year Ordering and Opening Times
Christmas & New Year Ordering and Opening Times 344 344 admin

Ordering & Opening Times

Christmas & New Year Ordering and Opening Times: Find out when our offices are open over the festive period, the times orders can be placed, and the delivery schedules during this time. read more

GBUKGroupICON
  • admin
  • No Comments

GBUK Group acquires Severn Healthcare Technologies
GBUK Group acquires Severn Healthcare Technologies 344 344 admin

GBUK Group, a portfolio company of A&M Capital Europe (“AMCE”), a London-based private equity firm with €650 million of commitments under management, has acquired UK-based Severn Healthcare Technologies (“Severn”), a value-added and fast-growing distributor of single-use medical devices.

Founded in 2014, Severn specialises in providing next-generation single-use medical devices across the Ear, Nose, and Throat (“ENT”) and Neuro-Otology clinical specialisms. Supporting the adoption of clinical innovation in operating theatres across the National Health Service (“NHS”) and the UK Private market, we believe Severn has built a reputation as a trusted partner to surgical clinicians on the foundations of deep technical expertise and exceeding customer service.

The acquisition of Severn represents GBUK’s second acquisition since AMCE’s investment in December 2023. The acquisition is expected to strengthen GBUK’s clinical specialist positioning further while expanding its product presence in two new and innovative therapeutic areas.

GBUK were advised by Rothschild & Co as financial adviser, Burness Paull as legal adviser, Accuracy as accounting adviser, and PMSI as commercial adviser.

About GBUK Group

Headquartered in the United Kingdom, GBUK Group designs develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The Company is a top 20 supplier to the UK NHS and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. GBUK Group has demonstrated a track record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinged on wrap-around services. To find out more, visit www.gbukgroup.com.

About A&M Capital Europe

AMCE is a London-headquartered private equity investment firm specialising in building pan-European platform companies through buy-and-build and organic growth initiatives. AMCE Fund I currently has €650 million of commitments under management, and Severn represents AMCE’s twenty-third transaction across its eight portfolio companies. More broadly, AMCE is part of A&M Capital, a multi-strategy private equity investment firm that manages commitments totalling ~€5.5 billion across all its investment strategies. In addition, A&M Capital maintains a strategic association with Alvarez & Marsal, one of the world’s largest growth and operationally focused advisory firms. For additional information, please visit A&M Capital Europe’s website at www.a-mcapital.com.

GBUKGroupICON
  • admin
  • No Comments

A&M Capital Europe Announces Majority Investment in GBUK Group
A&M Capital Europe Announces Majority Investment in GBUK Group 344 344 admin

A&M Capital Europe Announces Majority Investment in GBUK Group

January 9, 2024 – A&M Capital Europe (“AMCE”), a London-based middle-market private equity investment firm with €650 million of assets under management, announces the acquisition of a majority stake in GBUK Group (the “Company”), a leading global provider of specialist single-use medical devices, from H2 Equity Partners (“H2EP”).

Headquartered in the United Kingdom, GBUK designs, develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The Company is a top 20 supplier to the UK National Health Service (“NHS”) and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. GBUK has demonstrated a track record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinging on wrap-around services.

The partnership with AMCE is expected to enable GBUK to enhance patient care further and drive the innovation required to support the evolving needs of patients and healthcare providers. Leveraging GBUK’s intimate understanding of patient needs, new product development expertise and global supply-chain capabilities, the Company is well-positioned to continue delivering on this mission and support patients globally.

Additionally, with AMCE’s support, GBUK intends to pursue bolt-on acquisitions, focusing primarily on proprietary medical device specialists in the United Kingdom and broader European and North American markets.

GBUK will continue under the leadership of its existing management team, led by CEO Mike Geering, with Mike and his team investing alongside AMCE.

AMCE was advised by Weil, Gotshal & Manges as legal adviser, Houlihan Lokey as financial adviser, MDW Capital Partners as debt adviser, Boston Consulting Group as commercial adviser, Alvarez & Marsal as accounting and operational adviser, and EY as tax adviser.

About A&M Capital Europe

AMCE is a London-headquartered, middle-market private equity investment firm specialising in building pan-European platform companies through buy-and-build in the middle market. AMCE Fund I currently has €650 million of assets under management, and GBUK represents AMCE’s seventeenth transaction. More broadly, AMCE is part of A&M Capital, a multi-strategy private equity investment firm with ~€4.8 billion in assets under management across four investment strategies. In addition, A&M Capital maintains a strategic association with Alvarez & Marsal, one of the world’s largest operationally focused advisory firms. For additional information, please visit A&M Capital Europe’s website at www.a-mcapital.com.

Start Typing